A detailed history of Alta Advisers LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Alta Advisers LTD holds 2,300 shares of LLY stock, worth $1.83 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
2,300
Previous 2,300 -0.0%
Holding current value
$1.83 Million
Previous $2.08 Million 2.16%
% of portfolio
0.94%
Previous 1.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $105,038 - $123,826
200 Added 9.52%
2,300 $1.34 Million
Q3 2022

Oct 28, 2022

BUY
$296.48 - $337.87 $622,608 - $709,527
2,100 New
2,100 $679,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alta Advisers LTD Portfolio

Follow Alta Advisers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Advisers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Alta Advisers LTD with notifications on news.